A partnership between the European Union and the European pharmaceutical industry, IMI funds health research and innovation. It aims to speed up the development of better and safer medicines for patients, including those with neurological diseases. Cutting-edge technologies such as Artificial Intelligence are driving the attention for more cost-effective drug discovery strategies and personalized medicine applications.
More information is available here.